Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Operating Expenses | 7,108 | 11,360 | 4,102 | 2,608 | 4,681 |
Operating Income | -7,108 | -11,360 | -4,102 | -2,608 | -4,681 |
Other Income | 126 | 91 | 183 | 13 | 24 |
Pre-tax Income | -6,982 | -11,269 | -3,919 | -2,595 | -4,657 |
Net Income Continuous | -6,982 | -11,269 | -3,919 | -2,595 | -4,657 |
Net Income | $-6,982 | $-11,269 | $-3,919 | $-2,595 | $-4,657 |
EPS Basic Total Ops | -484.72 | -924.35 | -417.08 | -281.81 | -507.27 |
EPS Basic Continuous Ops | -482.41 | -924.33 | -417.85 | -284.11 | -512.06 |
EPS Diluted Total Ops | -484.72 | -924.35 | -417.08 | -281.81 | -507.27 |
EPS Diluted Continuous Ops | -482.41 | -924.33 | -417.85 | -284.11 | -512.06 |
EBITDA(a) | $-7,108 | $-11,360 | $-4,102 | $-2,608 | $-4,681 |